The role of copper dysregulation in Wilson disease

Copper dysregulation plays a central role in the pathogenesis of Wilson disease (WD). The disease arises from the body’s inability to regulate copper levels, leading to its accumulation and subsequent toxicity. Below is a detailed explanation of how copper dysregulation contributes to WD:

### 1. **Dysfunctional Copper Regulation:**

• In healthy individuals, copper homeostasis is tightly regulated. Excess copper is excreted into bile via the ATP7B protein, encoded by the ATP7B gene. However, in Wilson disease, mutations in the ATP7B gene impair the function of this protein, disrupting copper excretion.
• This dysfunction results in copper accumulation in hepatocytes (liver cells), as the body cannot eliminate the excess copper effectively.

### 2. **Pathogenic Mechanism:**

• The inability to excrete copper into bile leads to copper buildup in the liver. Over time, hepatocellular copper storage exceeds the liver's capacity, causing lysosomal toxicity and liver damage.
• As hepatocytes become damaged, free copper is released into the bloodstream, leading to systemic toxicity. This free copper is highly reactive and harmful to various tissues.

### 3. **Copper Toxicity and Free Radicals:**

• The cuprous ion (Cu⁺), the reduced form of copper, is highly reactive and generates free radicals. These free radicals cause oxidative stress and cellular damage unless copper is safely bound to intracellular chaperones.
• In Wilson disease, the lack of proper copper regulation allows free copper to accumulate, leading to oxidative damage in the liver, brain, and other organs.

### 4. **Systemic Effects of Copper Dysregulation:**

• Once free copper is released from damaged liver cells, it enters the bloodstream and causes toxicity in other tissues:
• **Red Blood Cells:** Free copper damages red blood cells, leading to hemolysis (destruction of red blood cells).
• **Brain:** Copper deposition in the brain, particularly in the basal ganglia, leads to neurological and psychiatric symptoms, such as movement disorders, tremors, and mood changes.
• The systemic effects of copper dysregulation are responsible for the multi-organ manifestations of Wilson disease.

### 5. **Diagnostic Indicators of Copper Dysregulation:**

• Key diagnostic markers of copper dysregulation in Wilson disease include:
• **Decreased ceruloplasmin levels:** Ceruloplasmin is the major copper-binding protein in plasma, but its levels are low in WD. However, it plays no direct role in copper metabolism.
• **Elevated non-ceruloplasmin-bound copper (free copper):** This form of copper is toxic and contributes to tissue damage.
• **Increased urinary copper excretion:** Urinary copper levels exceeding 100 μg/day are a hallmark of Wilson disease.
• **Exchangeable copper (CuEXC):** This is a newer diagnostic marker that measures the bioavailable, toxic form of copper. A ratio of exchangeable copper (REC) >18.5% is highly indicative of WD.

### 6. **Clinical Consequences of Copper Dysregulation:**

• The inability to regulate copper leads to two major patterns of organ damage:
• **Liver Damage:** Chronic copper accumulation in the liver causes inflammation, fibrosis, cirrhosis, and, in severe cases, fulminant hepatic failure. Fulminant Wilson disease is a rare, rapidly progressive form of the disease that can lead to death without emergency liver transplantation.
• **Neurological and Psychiatric Symptoms:** Copper deposition in the brain, particularly in the basal ganglia, results in movement disorders (e.g., tremors, dystonia, and rigidity), cognitive impairment, and psychiatric disturbances.

### 7. **Therapeutic Implications:**

• The cornerstone of Wilson disease management is reducing toxic free copper levels to prevent irreversible organ damage. This is achieved through:
• **Chelation Therapy:** Medications like D-penicillamine and trientine bind to free copper, facilitating its excretion through urine.
• **Zinc Therapy:** Zinc induces the production of intestinal metallothionein, which blocks copper absorption from the diet and reduces the amount of free copper in the body.
• **Combination or Sequential Therapy:** Depending on disease severity and side effects, chelators and zinc can be used together or alternated.
• **Liver Transplantation:** In cases of fulminant liver failure or advanced liver disease, transplantation may be the only life-saving option.
• **Gene Therapy:** Experimental ATP7B gene therapy offers hope for restoring copper transport in the future, although it is still in early stages of development.

### 8. **Importance of Early Detection:**

• Early detection of copper dysregulation is critical to prevent severe and irreversible damage to the liver and brain. Family screening and biochemical testing can identify at-risk individuals, enabling early intervention and treatment.

### Core Message:

The primary defect in Wilson disease is a failure of copper excretion due to ATP7B gene mutations, leading to copper dysregulation. This results in toxic copper accumulation in the liver, release into the bloodstream, and subsequent damage to multiple organs, including the liver, brain, and red blood cells. Early diagnosis and treatment aimed at reducing toxic free copper are essential to prevent life-threatening complications and improve outcomes for individuals with Wilson disease.